. Author manuscript; available in PMC: 2021 Nov 30.

Published in final edited form as: Transfusion. 2021 Aug 22;61(9):2756–2767. doi: 10.1111/trf.16625

TABLE 1.

Select changes by the US Food & Drug Administration in donor deferral criteria designed to reduce the risk of transmission of infectious diseases

Infectious disease	Donor category	Previous deferral^a	Current deferral^a
HIV⁵	Has exchanged sex for money or drugs	Indefinite	3 months
	Non-prescription injection drug use	Indefinite	3 months
	History of receiving allogeneic transfusion	12 months	3 months
	Nonsterile skin penetration with equipment contaminated with allogeneic blood or body fluids (e.g. needlestick)	12 months	3 months
	Men who have had sex with men	12 months	3 months
	Sexual contact with a person who has tested positive for HIV, or is at high risk of HIV infection (MSM, individuals who have exchanged money/drugs for sex, individuals who used non-prescription injection drugs)	12 months	3 months
Malaria⁶	Travel to a malaria-endemic area	12 months	3 months
CJD and variant CJD⁷	Has a blood relative diagnosed with familial CJD	Indefinite	Permanent

Abbreviations: CJD, Creutzfeldt–Jakob Disease; HIV, human immunodeficiency virus; MSM, men who have sex with men.

Months since the most recent event, contact, or departure from a geographic area.